| Not Yet Recruiting | A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adul NCT07513129 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult NCT07302347 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Not Yet Recruiting | CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors NCT07297160 | Baylor College of Medicine | Phase 1 |
| Not Yet Recruiting | CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma NCT07383233 | Qi deng | Phase 1 |
| Not Yet Recruiting | A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship NCT07013435 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma NCT07502872 | Brown University | Phase 2 |
| Not Yet Recruiting | Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event NCT07499128 | National Cancer Institute (NCI) | N/A |
| Not Yet Recruiting | Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers NCT07524530 | National Cancer Institute (NCI) | Phase 2 |
| Not Yet Recruiting | Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors NCT07014293 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Clonal Hematopoiesis of Immunological Significance NCT05969821 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Precision Physical Exercise for Personalized Onco-Hematology. NCT07286539 | University of Salamanca | N/A |
| Not Yet Recruiting | HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors NCT07483749 | The Children's Hospital of Zhejiang University School of Medicine | — |
| Recruiting | CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL NCT07294677 | University of Chicago | Phase 1 / Phase 2 |
| Recruiting | Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients U NCT06856226 | National Cancer Institute (NCI) | — |
| Recruiting | Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968 | Medical College of Wisconsin | Phase 1 |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma NCT07249905 | ModeX Therapeutics, An OPKO Health Company | Phase 1 / Phase 2 |
| Recruiting | Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma NCT06510309 | Gottfried von Keudell, MD PhD | Phase 2 |
| Not Yet Recruiting | PET-CT in Lymphoma Among the Eldery NCT07259941 | Assiut University | — |
| Recruiting | An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers NCT07226934 | Washington University School of Medicine | N/A |
| Recruiting | GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymp NCT07138547 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies NCT07316907 | YANRU WANG | Phase 1 |
| Not Yet Recruiting | Shanghai Lymphoma Clinical Cohort NCT07285174 | Ruijin Hospital | — |
| Recruiting | Mosunetuzumab for CLL MRD Clearance NCT07052695 | Inhye Ahn | Phase 1 / Phase 2 |
| Recruiting | A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With NCT07015242 | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Phase 2 |
| Recruiting | xDRIVE for Florida-based Cancer Patients NCT07167381 | First Ascent Biomedical Inc. | N/A |
| Not Yet Recruiting | A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies NCT07107204 | Biotroy Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in P NCT06441331 | ITM Solucin GmbH | Phase 1 |
| Recruiting | HEME Home Transfusion Program NCT06487247 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Odronextamab in Low Tumor Volume Advanced FL NCT07128641 | Gottfried von Keudell, MD PhD | Phase 2 |
| Not Yet Recruiting | Virus-associated Tumour Microenvironment NCT06471296 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies NCT07131449 | The First Affiliated Hospital of Xinxiang Medical College | — |
| Recruiting | Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy NCT07390071 | University of Utah | N/A |
| Recruiting | AI-assisted Diagnosis of Malignant Brain Tumors NCT07198256 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Not Yet Recruiting | The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR NCT07020260 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Withdrawn | A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma NCT07030699 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Not Yet Recruiting | CD30 CAR-T in the Treatment of CD30 Positive Lymphoma NCT07048353 | Shandong Qilu Cell Therapy Engineering Technology Co., Ltd | EARLY_Phase 1 |
| Recruiting | A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxi NCT06859424 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Recruiting | WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring) NCT07058064 | Mayo Clinic | N/A |
| Recruiting | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Can NCT06371768 | Duke University | N/A |
| Recruiting | Randomised Controlled Trial of Artificial Intelligence-assisted Health Education NCT07305337 | Zhongnan Hospital | N/A |
| Recruiting | A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties NCT07052916 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Mali NCT05237986 | National Cancer Institute (NCI) | — |
| Recruiting | A Phase I Dose Finding Study of MB-CART2219.1 NCT07108868 | University Hospital Tuebingen | Phase 1 |
| Recruiting | TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas NCT07082803 | Treeline Biosciences, Inc. | Phase 1 |
| Recruiting | Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR NCT07472972 | University of Zurich | — |
| Recruiting | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving NCT06923397 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Combating Cancer-Related Fatigue: A Personalized Supportive Care Program NCT06860880 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma NCT06557330 | Fox Chase Cancer Center | Phase 2 |
| Recruiting | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell NCT06522737 | SecuraBio | Phase 3 |
| Recruiting | Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma NCT06883526 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 1 / Phase 2 |
| Recruiting | Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538 | Peking University First Hospital | — |
| Recruiting | Mosaic Trial for Stem Cell Transplant Recipients NCT06960993 | Northwestern University | N/A |
| Recruiting | A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Rel NCT06624085 | Hoffmann-La Roche | Phase 1 |
| Recruiting | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib ( NCT06854003 | Christine Ryan | Phase 2 |
| Recruiting | Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) NCT06954805 | Jennifer Amengual | Phase 2 |
| Recruiting | Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Inten NCT06409767 | University Hospital, Angers | N/A |
| Active Not Recruiting | Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma NCT07094477 | Daihong Liu | Phase 2 |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Not Yet Recruiting | Hypofractionation Radiotherapy in Combination with Glofitamab in Relapsed/refractory Diffuse B-cell Lymphoma w NCT06867536 | Liling Zhang | Phase 2 |
| Recruiting | A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma NCT06915246 | VIVUS LLC | Phase 2 |
| Recruiting | Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's S NCT06967038 | Bangdong Gong | Phase 1 / Phase 2 |
| Recruiting | ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis NCT06680661 | Leland Metheny | Phase 2 |
| Recruiting | Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma NCT06826118 | The First Affiliated Hospital of Xiamen University | Phase 2 |
| Recruiting | Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care NCT05745285 | University of Miami | N/A |
| Terminated | YASU Research Registry: For Young Adults With Cancer NCT06275854 | Young Adult Survivors United | — |
| Not Yet Recruiting | Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of NCT06817759 | Ciusss de L'Est de l'Île de Montréal | N/A |
| Recruiting | The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease NCT06795815 | Azienda USL Reggio Emilia - IRCCS | N/A |
| Completed | RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study NCT06790420 | Pfizer | — |
| Recruiting | Epco, Zanu, Ritux for R/R FL or MZL NCT06563596 | Reid Merryman, MD | Phase 2 |
| Active Not Recruiting | Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia NCT06944119 | Tel-Aviv Sourasky Medical Center | — |
| Withdrawn | Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells NCT07071909 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma NCT06737835 | Assiut University | — |
| Recruiting | A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies NCT06971523 | CytosinLab Therapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Withdrawn | Tazemetostat Plus CHOP in 1L T-cell Lymphoma NCT06692452 | Eric Jacobsen, MD | Phase 2 |
| Recruiting | CD70-targeted immunoPET Imaging of Malignant Cancers NCT06852638 | RenJi Hospital | N/A |
| Recruiting | A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma NCT06733441 | Treeline Biosciences, Inc. | Phase 1 |
| Recruiting | ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL NCT06693830 | Hua-Jay J Cherng, MD | N/A |
| Recruiting | A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma NCT06563505 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Maligna NCT07270263 | Medical University of Gdansk | N/A |
| Recruiting | Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy NCT06510361 | Beth Israel Deaconess Medical Center | Phase 2 |
| Recruiting | A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 NCT06698003 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Enrolling By Invitation | Feasibility of Intermittent Fasting During Chemotherapy NCT06645093 | University of Oslo | N/A |
| Recruiting | Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes NCT07155954 | Peking University Third Hospital | — |
| Recruiting | Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL NCT06475235 | Dana-Farber Cancer Institute | Phase 1 |
| Recruiting | CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies NCT06326463 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study. NCT06660446 | Biogipuzkoa Health Research Institute | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | Navigating the Clinical Research Process for Lymphoma NCT06070246 | Power Life Sciences Inc. | — |
| Recruiting | Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral NCT06398457 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | EARLY_Phase 1 |
| Terminated | DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase) NCT05010369 | University of Exeter | N/A |
| Not Yet Recruiting | Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL NCT06573151 | Ruijin Hospital | Phase 2 |
| Not Yet Recruiting | A Real-World Study on Extranodal Lymphoma NCT06573099 | Ruijin Hospital | — |
| Recruiting | Digital Peer Navigation for Adolescents and Young Adults With Cancer NCT06193369 | University Health Network, Toronto | N/A |
| Recruiting | Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL) NCT06592170 | The First Hospital of Jilin University | Phase 1 / Phase 2 |
| Recruiting | Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing NCT06550427 | National Taiwan University Hospital | — |
| Active Not Recruiting | Zanubrutinib in Primary Cold Agglutinin Disease NCT06067048 | Stichting Hemato-Oncologie voor Volwassenen Nederland | Phase 2 |
| Recruiting | PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) NCT06430736 | Insel Gruppe AG, University Hospital Bern | Phase 2 |
| Recruiting | DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics NCT06296368 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) NCT06343311 | Estrella Biopharma, Inc. | Phase 1 / Phase 2 |
| Recruiting | Intratumoral CAN2109 in Subjects With Solid Tumors NCT06332430 | Canwell Biotech Limited | Phase 1 |
| Active Not Recruiting | Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors NCT06053268 | St. Jude Children's Research Hospital | N/A |
| Enrolling By Invitation | Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound NCT06848738 | Zealand University Hospital | N/A |
| Recruiting | Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymph NCT06585124 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Interest of Light Therapy in Hematology - The PHOTO-TREAT Study NCT06326268 | Institut de cancérologie Strasbourg Europe | N/A |
| Recruiting | Mediastinal EBUS Cryobiopsy Study In Sweden NCT06347939 | Region Skane | — |
| Recruiting | Effects of Exercise Training in Survivors of Lymphoma NCT06270667 | Norwegian School of Sport Sciences | N/A |
| Not Yet Recruiting | RAT-HEMATO : Return to Work After Malignant Hemopathy NCT06262789 | University Hospital, Angers | N/A |
| Recruiting | Living Well With Lymphoma NCT06047626 | University of Michigan Rogel Cancer Center | N/A |
| Active Not Recruiting | First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228 NCT05737628 | Byondis B.V. | Phase 1 |
| Recruiting | AGMT Austrian Lymphoma Registry NCT06294652 | Arbeitsgemeinschaft medikamentoese Tumortherapie | — |
| Recruiting | Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therap NCT06218602 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large NCT06774326 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Improved Early Diagnosis in Female Pelvic Cancer With OC Detect NCT06613230 | Region Skane | — |
| Recruiting | AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haem NCT06137144 | AstraZeneca | Phase 1 / Phase 2 |
| Recruiting | Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET NCT05654675 | Academisch Ziekenhuis Maastricht | — |
| Recruiting | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Pos NCT05770037 | Cancer Research UK | Phase 2 / Phase 3 |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantati NCT06001385 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Active Not Recruiting | Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematolog NCT06026046 | University Hospital, Angers | N/A |
| Recruiting | Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy NCT05921253 | University of Oklahoma | EARLY_Phase 1 |
| Recruiting | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801 | Children's Hospital Medical Center, Cincinnati | — |
| Unknown | CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study NCT06106776 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Unknown | Lapelga vs Gastrofil NCT06116734 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 3 |
| Active Not Recruiting | Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplanta NCT06328699 | Emory University | N/A |
| Recruiting | Whole Body MRI in Oncology NCT06895291 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | — |
| Recruiting | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refra NCT06084936 | Hoffmann-La Roche | Phase 3 |
| Completed | A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers NCT06010680 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Active Not Recruiting | Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors NCT06049134 | M.D. Anderson Cancer Center | Phase 4 |
| Recruiting | The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person NCT05509751 | Martine Puts | N/A |
| Unknown | CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy NCT06202885 | Seoul St. Mary's Hospital | — |
| Active Not Recruiting | Muscle Dysfunction in Patients With Haematological Diseases NCT05150561 | Rigshospitalet, Denmark | — |
| Recruiting | Real-World Study of DLBCL With Different Genetic Subtypes NCT06026488 | Ruijin Hospital | — |
| Recruiting | Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMON NCT05891821 | Immune Oncology Research Institute | Phase 2 |
| Recruiting | High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523 | Yigeng Cao,MD,PhD | — |
| Recruiting | Eltrombopag for Peripheral Blood Stem Cell Harvest NCT05961410 | National Taiwan University Hospital | Phase 2 |
| Unknown | Elastography and Treatment of Lymphoma NCT05967975 | Assiut University | — |
| Not Yet Recruiting | L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH NCT05775705 | Beijing Friendship Hospital | Phase 3 |
| Unknown | Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma NCT04977167 | HitGen Inc. | Phase 1 |
| Recruiting | A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma NCT05929612 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma NCT05948033 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Recruiting | Integrative Medicine in Lymphoma Survivors NCT05982223 | Bnai Zion Medical Center | N/A |
| Recruiting | Virtual Rehabilitation for Cancer Survivors NCT05898789 | University Health Network, Toronto | N/A |
| Unknown | Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma NCT05922384 | Affiliated Hospital of Guangdong Medical University | N/A |
| Recruiting | Combination of CAR-DC Vaccine and ICIs in Malignant Tumors NCT05631886 | Chinese PLA General Hospital | Phase 1 |
| Recruiting | Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers NCT05940272 | Memorial Sloan Kettering Cancer Center | N/A |
| Unknown | A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types NCT05907447 | Ruijin Hospital | — |
| Recruiting | Assessing the Presence of CT-DNA in Lymphoma Associated HLH NCT05702502 | Nottingham University Hospitals NHS Trust | — |
| Recruiting | The Pathogenesis and Prognostic Factors of Lymphoma NCT06203652 | Shanghai Zhongshan Hospital | — |
| Completed | Retun-to-school Adaptation Program for Children With Cancer NCT06389357 | Gazi University | N/A |
| Completed | Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study NCT06063603 | Mayo Clinic | N/A |
| Recruiting | A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Re NCT05683171 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502 | AIDS Malignancy Consortium | — |
| Unknown | Musculoskeletal Health in Adult Haematological Cancer Survivors NCT05865678 | The Christie NHS Foundation Trust | — |
| Recruiting | Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis NCT05898477 | University of Alabama at Birmingham | — |
| Unknown | the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma NCT05834751 | Ou Bai, MD/PHD | N/A |
| Recruiting | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia NCT06236373 | University of Modena and Reggio Emilia | — |
| Recruiting | A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphom NCT05800366 | Jennifer Crombie, MD | Phase 2 |
| Completed | Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies NCT05371054 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Telerehabilitation in Hemato-oncological Survivors NCT05779605 | Brno University Hospital | N/A |
| Recruiting | Use of GnRHa During Chemotherapy for Fertility Protection NCT05328258 | Kenny Rodriguez-Wallberg | Phase 3 |
| Recruiting | Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma NCT05346809 | Divaya Bhutani | Phase 2 |
| Recruiting | Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Tr NCT05006482 | University of Rochester | Phase 3 |
| Terminated | SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. NCT05293912 | Hangzhou Sumgen Biotech Co., Ltd. | Phase 1 |
| Recruiting | Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type NCT05477264 | Won Seog Kim | Phase 2 |
| Withdrawn | A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT05431179 | Oncternal Therapeutics, Inc | Phase 3 |
| Unknown | Penpulimab in Maintenance Therapy in Lymphoma NCT05680038 | WEI XU | — |
| Completed | A Study of People With CD30 Positive Lymphoma in China NCT05506774 | Takeda | — |
| Recruiting | Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Re NCT05676450 | M.D. Anderson Cancer Center | N/A |
| Completed | Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunot NCT05763563 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Active Not Recruiting | A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Predni NCT05673785 | Takeda | Phase 2 |
| Not Yet Recruiting | Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma NCT05681403 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Withdrawn | Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy NCT05362331 | University of California, San Francisco | N/A |
| Recruiting | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular T NCT05646576 | Massachusetts General Hospital | N/A |
| Terminated | ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals NCT05655546 | Scripps Translational Science Institute | N/A |
| Recruiting | Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas NCT05751798 | OSE Immunotherapeutics | Phase 1 / Phase 2 |
| Unknown | Plerixafor for Poorly Mobilized Lymphoma NCT05510544 | Peking University | Phase 4 |
| Unknown | A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma NCT05852028 | Ruijin Hospital | — |
| Completed | Improving Patient Experience: BMBA NCT05690230 | Thomas Jefferson University | N/A |
| Terminated | Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors NCT05698888 | Virtuoso BINco, Inc. | Phase 1 |
| Recruiting | Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Ad NCT05858424 | Centre Leon Berard | N/A |
| Active Not Recruiting | A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Pati NCT05495464 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplan NCT05813132 | Rehab Werida | N/A |
| Completed | A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Mal NCT05567887 | Pfizer | Phase 1 |
| Unknown | Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH NCT05600959 | Beijing Friendship Hospital | — |
| Unknown | Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients Wi NCT05536154 | The Affiliated People's Hospital of Ningbo University | N/A |
| Unknown | PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma NCT05565898 | Assiut University | — |
| Completed | A Study of Chinese Adults With Lymphoma NCT05288491 | Takeda | — |
| Active Not Recruiting | Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocyt NCT05479994 | BeiGene | Phase 2 |
| Completed | Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Can NCT04593277 | Fred Hutchinson Cancer Center | N/A |
| Completed | High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology NCT04940468 | University of Colorado, Denver | N/A |
| Completed | Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Ma NCT05101759 | University Hospital, Toulouse | N/A |
| Recruiting | A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-c NCT05464719 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker NCT05501379 | University Medicine Greifswald | — |
| Terminated | A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory NCT05244070 | Bristol-Myers Squibb | Phase 1 |
| Recruiting | Vaccine Responses in Patients With B Cell Malignancies NCT05170399 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
| Active Not Recruiting | A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant NCT05540340 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies NCT05618041 | Hebei Senlang Biotechnology Inc., Ltd. | N/A |
| Unknown | A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma NCT05446688 | Mabwell (Shanghai) Bioscience Co., Ltd. | Phase 2 |
| Recruiting | Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adol NCT05873322 | Aarhus University Hospital | — |
| Recruiting | A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma NCT05341557 | Betta Pharmaceuticals Co., Ltd. | Phase 1 |
| Recruiting | A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyp NCT05357651 | L & L Bio Co., Ltd., Ningbo, China | Phase 1 |
| Recruiting | Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematologica NCT05444348 | Christoffer Johansen | N/A |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma NCT05464823 | M.D. Anderson Cancer Center | N/A |
| Completed | Comparative Quantification of MTX and Its Metabolites Post Glucarpidase NCT05250869 | Charite University, Berlin, Germany | — |
| Active Not Recruiting | A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. NCT05878691 | Glenmark Specialty S.A. | Phase 1 |
| Recruiting | SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes NCT05754814 | Rigshospitalet, Denmark | — |
| Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) NCT05403177 | University Health Network, Toronto | — |
| Recruiting | Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR NCT05371132 | City of Hope Medical Center | Phase 1 |
| Unknown | A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in NCT05390528 | Shanghai Henlius Biotech | Phase 1 / Phase 2 |
| Recruiting | Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis NCT05388838 | Hospices Civils de Lyon | N/A |
| Recruiting | Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV NCT07032103 | Samsung Medical Center | — |
| Unknown | Endobronchial Ultrasound Needle Aspiration With and Without Suction NCT05110950 | Università Politecnica delle Marche | N/A |
| Unknown | Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies NCT05275036 | Sun Yat-sen University | — |
| Recruiting | A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma NCT05389293 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Enrolling By Invitation | Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients NCT05396118 | Rigshospitalet, Denmark | Phase 2 |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Completed | A Retrospective Study on Extranodal DLBCL NCT06549361 | Ruijin Hospital | — |
| Recruiting | Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma NCT05294055 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Unknown | Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multipl NCT06060080 | Yao Liu | N/A |
| Recruiting | Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma NCT05294367 | Mayo Clinic | EARLY_Phase 1 |
| Recruiting | Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation NCT05135351 | University of Nebraska | N/A |
| Recruiting | Early Integration of Palliative and Supportive Care in Cellular Therapy NCT05190653 | Alberta Health Services, Calgary | N/A |
| Completed | Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Chil NCT05095155 | Asfendiyarov Kazakh National Medical University | — |
| Completed | Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant NCT05338047 | Hospital Universitario Dr. Jose E. Gonzalez | Phase 2 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophospham NCT04980222 | Hoffmann-La Roche | Phase 2 |
| Completed | Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transpla NCT05274763 | Emory University | N/A |
| Completed | PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation NCT05120570 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Enrolling By Invitation | Long-Term Follow-up Study NCT05332054 | Caribou Biosciences, Inc. | — |
| Completed | Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy NCT05064787 | Pack Health | N/A |
| Unknown | Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells NCT06026995 | Chongqing University Cancer Hospital | Phase 4 |
| Withdrawn | Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leuk NCT04961801 | Shin Mineishi | Phase 1 / Phase 2 |
| Unknown | A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. NCT05598268 | ImmVira Pharma Co. Ltd | Phase 1 / Phase 2 |
| Unknown | Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory an NCT05239676 | Zhejiang University | EARLY_Phase 1 |
| Unknown | Phase 1 First-in-human Study of JS014 NCT05296772 | Anwita Biosciences | Phase 1 |
| Recruiting | UPLYFT For Lymphoma Survivors NCT05080166 | Dana-Farber Cancer Institute | N/A |
| Active Not Recruiting | Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT NCT05493800 | MitoImmune Therapeutics | Phase 2 |
| Completed | Feasibility, Acceptability, and Preliminary Effects of Lymfit NCT05259657 | McGill University | N/A |
| Recruiting | Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH) NCT06781437 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients NCT05214144 | Yale University | — |
| Terminated | Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutatio NCT05153330 | Biomea Fusion Inc. | Phase 1 |
| Recruiting | REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs NCT05223413 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | N/A |
| Recruiting | Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors NCT05257785 | McGill University | N/A |
| Completed | Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors NCT05378256 | Centre Hospitalier Régional d'Orléans | N/A |
| Recruiting | Danish Elder Lymphoma Patient Hematopoietic Investigation NCT05245487 | Rigshospitalet, Denmark | — |
| Unknown | PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells NCT05176275 | The First Affiliated Hospital of Soochow University | N/A |
| Unknown | Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) M NCT05155215 | Beijing Immunochina Medical Science & Technology Co., Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Mali NCT05055791 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors NCT05156203 | Taivex Therapeutics Corporation | Phase 1 |
| Unknown | A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects NCT05049083 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Active Not Recruiting | A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma NCT05081479 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Italian Study of Patients With Lymphoma NCT06814925 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Enrolling By Invitation | Quest to Analyze One Thousand Humans Meditating NCT06583395 | Tobias Moeller-Bertram | — |
| Active Not Recruiting | Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy fo NCT04541212 | Montreal Heart Institute | — |
| Unknown | PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantatio NCT05156554 | Sun Yat-sen University | N/A |
| Recruiting | The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinica NCT04957901 | Sun Yat-sen University | — |
| Completed | A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With NCT05093322 | Hutchmed | Phase 1 / Phase 2 |
| Unknown | Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma NCT05320081 | Huazhong University of Science and Technology | Phase 2 |
| Withdrawn | SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies NCT05393999 | Imperial College Healthcare NHS Trust | Phase 2 |
| Recruiting | Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant NCT04898790 | University of Nebraska | N/A |
| Unknown | Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignanc NCT05203809 | Malaghan Institute of Medical Research | — |
| Recruiting | A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced NCT04827810 | Fox Chase Cancer Center | Phase 1 |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Completed | Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant NCT04985409 | Cedars-Sinai Medical Center | N/A |
| Completed | Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide NCT06069024 | Qianfoshan Hospital | — |
| Completed | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal NCT05078593 | Shanghai Henlius Biotech | Phase 1 |
| Unknown | Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma NCT04931875 | RenJi Hospital | — |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide NCT04904588 | Center for International Blood and Marrow Transplant Research | Phase 2 |
| Active Not Recruiting | Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma NCT05019976 | University of Chicago | N/A |
| Active Not Recruiting | SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer NCT04977024 | GeoVax, Inc. | Phase 2 |
| Recruiting | Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies NCT05528887 | The Affiliated People's Hospital of Ningbo University | Phase 1 |
| Unknown | Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT NCT04764513 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Completed | A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma NCT04970992 | Da Zen Theranostics Inc | Phase 1 |
| Completed | To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumor NCT06558513 | Evopoint Biosciences Inc. | Phase 1 / Phase 2 |
| Unknown | A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma NCT04983810 | Cyclacel Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Completed | Removing Transfusion Dependence as a Barrier to Hospice Enrollment NCT05063591 | Adam Olszewski | N/A |
| Recruiting | Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Rel NCT04739813 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 NCT04556266 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase) NCT04162431 | University of Exeter | — |
| Terminated | Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemoth NCT04716153 | University Hospital, Montpellier | N/A |
| Terminated | ALPN-202 With PD-1 Inhibition in Advanced Malignancies NCT04920383 | Alpine Immune Sciences, Inc. | Phase 1 |
| Completed | IIT2020-20-SHIRAZIP-WALK: Nature Walks NCT04896580 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma NCT04837222 | Takeda | — |
| Recruiting | CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANT NCT04637763 | Caribou Biosciences, Inc. | Phase 1 |
| Completed | Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of A NCT04703985 | University Hospital, Bordeaux | — |
| Recruiting | A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumo NCT04570423 | Spectrum Pharmaceuticals, Inc | Phase 2 |
| Unknown | An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lym NCT04873440 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Unknown | Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction NCT05892146 | National Cheng-Kung University Hospital | N/A |
| Completed | Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT NCT04194840 | Case Comprehensive Cancer Center | N/A |
| Completed | A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic NCT04847050 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymp NCT04818372 | Keymed Biosciences Co.Ltd | Phase 1 |
| Unknown | Endobronchial Diagnosis of Lymphoma NCT05075655 | University Hospital, Caen | N/A |
| Suspended | HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous NCT04668768 | Fox Chase Cancer Center | Phase 2 |
| Completed | A Feasibility Study in Chronically Fatigued Cancer Survivors NCT04931407 | Oslo University Hospital | N/A |
| Completed | Predictors of Malnutrition in Patients With Haematological Cancer NCT05209321 | Jens Rikardt Andersen | — |
| Unknown | Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patien NCT04797182 | Sun Yat-sen University | Phase 2 |
| Unknown | Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma NCT04910594 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 3 |
| Completed | Telerehabilitation and Lymphoma Patients NCT04822389 | Brno University Hospital | N/A |
| Completed | Pilot Study of an NTproBNP Guided Strategy of Cardioprotection NCT04737265 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Unknown | Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL NCT03271515 | Beijing Doing Biomedical Co., Ltd. | Phase 1 |
| Unknown | Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL NCT02546739 | Beijing Doing Biomedical Co., Ltd. | Phase 1 |